Objective: To evaluate the effects of gonadotropin-releasing hormone agonists (GnRH-a) on fertility in women with mild endometriosis who are undergoing in vitro fertilization and embryo transfer (IVF-ET) procedures.

Design: Prospective, randomized, controlled trial.

Setting: Three tertiary university hospitals.

Patient(s): Four hundred infertile women with mild endometriosis, documented with laparoscopy, undergoing IVF and 200 women with tubal factor infertility.

Intervention(s): Administration of GnRH-a for 3 months before an IVF attempt (group A, n = 200) or IVF without GnRH-a (group B, n = 200).

Main Outcome Measure(s): Follicular fluid (FF) levels of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), IL-6, IL-8, and IL-1 receptor antagonist; fertilization rate (FR), implantation rate (IR), quality of embryos, and clinical pregnancy rate (PR).

Result(s): Women who received GnRH-a had a statistically significantly reduced concentration of FF cytokines compared with women who did not receive this regimen. Women in group B had a reduced FR (61.7; 95% CI, 59.20-64.20) compared with the women in group A (72.7; 95% CI, 70.50-74.90) and compared with the women with tubal factor infertility (74.7; 95% CI, 72.00-77.24). The embryo quality, IR, and clinical PR showed no statistically significant improvement in the women of group A compared with group B.

Conclusion(s): Women who received GnRH-a for 3 months had a lower concentration of FF cytokines. These women had also a higher FR than the women who did not receive GnRH-a. However, the IR, embryo quality, and clinical PR showed no statistically significant difference when comparing the two groups. CLINICALTRIALS.

Gov Id: NCT01269125.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2019.12.018DOI Listing

Publication Analysis

Top Keywords

women
13
women mild
12
mild endometriosis
12
compared women
12
women group
12
gonadotropin-releasing hormone
8
hormone agonists
8
in vitro fertilization
8
fertilization rate
8
clinical pregnancy
8

Similar Publications

Objectives: There have been conflicting reports about the frequency of neural autoantibodies in epilepsy cohorts, which is confounded by the lack of clear distinction of epilepsy from acute symptomatic seizures due to encephalitis. The aim of this study was to determine the frequency of neural autoantibodies in a well characterised population of refractory focal epilepsy of known and unknown cause.

Methods: Cases were recruited from epilepsy outpatient clinics at the Princess Alexandra, Mater, Royal Brisbane and Women's and Cairns Base Hospitals from 2021 - 2023.

View Article and Find Full Text PDF

Background: Disparities in labor epidural analgesia (LEA) management could reduce maternal satisfaction and increase risk. We compared times from the first administration of breakthrough pain medication (top-up) to LEA replacement to evaluate disparities across race.

Methods: In this retrospective cohort study (01-01-2018 to 12-31-2022), all patients with LEA and maternal race/ethnicity of non-Hispanic White or Black were eligible.

View Article and Find Full Text PDF

Background: Although existing disease preparedness and response frameworks provide guidance about strengthening emergency response capacity, little attention is paid to health service continuity during emergency responses. During the 2014 Ebola outbreak, there were 11,325 reported deaths due to the Ebola virus and yet disruption in access to care caused more than 10,000 additional deaths due to measles, HIV/AIDS, tuberculosis, and malaria. Low- and middle-income countries account for the largest disease burden due to HIV, tuberculosis, and malaria and yet previous responses to health emergencies showed that HIV, tuberculosis, and malaria service delivery can be significantly disrupted.

View Article and Find Full Text PDF

Sex, Gender, and Sexuality in the .

N Engl J Med

January 2025

From the Office of Diversity Inclusion and Community Partnership (J.Y.R.), the Department of Medicine (J.Y.R.), and the Department of Global Health and Social Medicine (D.S.J.), Harvard Medical School; the Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health (J.Y.R.); the Department of Medicine, Section of General Internal Medicine, Boston University Chobanian and Avedisian School of Medicine (C.G.S.); and the GenderCare Center, Boston Medical Center (C.G.S.) - all in Boston; the Department of the History of Science (B.M., J.M., A.H., S.S.R.), and the Committee on Degrees in Studies of Women, Gender, and Sexuality (S.S.R.), Harvard University, Cambridge, MA; Board of Directors, Tegan and Sara Foundation, Santa Monica, CA. (J.H.); and the Departments of History and of Sexuality, Women's, and Gender Studies, Amherst College, Amherst, MA (J.M.).

View Article and Find Full Text PDF

Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age.

N Engl J Med

January 2025

From the Department of Medicine, University of Auckland, Auckland, New Zealand (M.J.B., Z.N., A.M., C.G., V.P., B.M., A.G., I.R.R., G.G., A.H.); the Department of Psychology, Stanford University, Stanford, CA (C.G.); and the Department of Radiology, Starship Hospital, Auckland, New Zealand (S.B.).

Background: Zoledronate prevents fractures in older women when administered every 12 to 18 months, but its effects on bone density and bone turnover persist beyond 5 years. Whether infrequent zoledronate administration would prevent vertebral fractures in early postmenopausal women is unknown.

Methods: We conducted a 10-year, prospective, double-blind, randomized, placebo-controlled trial involving early postmenopausal women (50 to 60 years of age) with bone mineral density T scores lower than 0 and higher than -2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!